Haima Therapeutics

: Haima Therapeutics is a biotechnology company based in Cleveland, Ohio. The company is a privately held entity focused on developing innovative therapies for bleeding disorders. Haima Therapeutics specializes in developing novel hemostatic therapies, with a particular focus on nanoparticle-based solutions. Their technology aims to address the challenges of controlling bleeding by leveraging the body's natural clotting mechanisms. Haima Therapeutics's key differentiator lies in its proprietary SynthoPlate technology. This innovative platform utilizes nanoparticles to effectively bind to the site of injury, promoting rapid and controlled clotting. This approach offers potential advantages over traditional hemostatic agents, including improved efficacy and reduced risk of complications. For inquiries or further information, please contact Haima Therapeutics directly.